CODING CHALLENGE: Is V58.11 Right for Patient Not on Chemo?
Posted on 30. Dec, 2008 by Editor in Coding Challenge
Question: When you use a chemo admin code for a drug that isn’t chemo (such as Remicade or IVIG), should you still report V58.11?
Answer: No. You should report V58.11 (Encounter for antineoplastic chemotherapy) only for patients receiving chemotherapy. If you report a chemotherapy code for antineoplastic immunotherapy, you may report V58.12 (Encounter for antineoplastic immunotherapy) instead. If you use a chemotherapy code for a substance that is not antineoplastic, such as Remicade, you should not use either V58.11 or V58.12.
Got more questions on oncology coding? Get two audioconferences — and two CEUs — in one package.
Click here to login and get access to this article if you already receive the CodingNews Wire
If you've already signed in and are still seeing this screen, click here to refresh the page.
If you've already signed in and are still seeing this screen, click here to refresh the page.
CodingNews Wire
Free registration required for full access to articles.
You will also receive
- Free updates on CPT, ICD-9, HCPCS, Medicare, NCCI edits, and ICD-10.
- Discounts on 3rd party offers
Loading ...
H
18. Dec, 2009
Then what is code that is to be used? you really did not aswer the questions